RxRevu: Funding, Investors & Team (Sep 2026)
RxRevu is a physician-founded organization on a mission to become the leader in prescription decision support, helping prescribers identify the most cost-effective medications for each patient, at the point of care. RxRevu was referred to as the “Google of Drugs” by CNBC and is currently working with health systems, PBMs, and electronic health records (EHR) vendors. RxRevu’s EHR-embedded technology allows prescribers to view prior authorizations and real-time, patient-specific cost and drug options aligned with formulary and benefit data. This information is provided directly from the payer/PBM to inform the prescriber before medication selection. In addition, the platform provides prescription health analytics to help organizations understand prescribing behavior and drive consistent prescribing practices in line with an organization's best practices.
RxRevu has raised $15.0M across 2 funding rounds on record, the most recent an undisclosed round of $8.0M announced in Jun 2021.
That round is above the $5.3M median round size for Data and Analytics companies tracked on FundedIQ over the last two years.
RxRevu Company Profile and Key Stats
Latest funding round on record: Jun 2021.
RxRevu Funding Rounds
RxRevu raised $7.0M in a Series B announced in Jan 2021.
5 months later, an undisclosed round of $8.0M was announced in Jun 2021.
RxRevu Founders and Leadership Team
Contact details for the RxRevu team: 1 of 2 have an email address on file.
Start 14-day free trial →RxRevu Funding Compared to Other Data and Analytics Startups
RxRevu's latest round of $8.0M is above the median round in Data and Analytics. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RxRevu in Data and Analytics and Denver
Companies Similar to RxRevu
IDMission offers cutting-edge technology for Identity Verification. Through IDMission, businesses can create…
TRM Labs is a blockchain intelligence startup that aids financial institutions, cryptocurrency companies, and…
Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a…
Euno is a platform for governing data models that offers a new and innovative way to handle dynamic data. It…
CivilGrid is a platform that uses various types of data related to utilities, environment, and geotechnics to…
Wavelogix creates a platform for monitoring and testing infrastructure using IoT sensors and data analytics.…
Centralize is a tech company that uses tools and input from stakeholders to assess interactions at different…
Abstract Security has created a revolutionary platform, equipped with an AI-powered assistant, to better…
Venus Aerospace is a start-up company pushing the boundaries of high speed transportation.
Masuda Group LLC is a direct-source audience supplier providing first-party respondent ecosystems for global…
Cirata is a vendor that provides collaboration software for the software development industry.
Commercialising an X-ray technique developed within Lawrence Livermore, in conjunction with the SLAC National…
RxRevu Funding FAQs
What does RxRevu do?
RxRevu is a physician-founded organization on a mission to become the leader in prescription decision support, helping prescribers identify the most cost-effective medications for each patient, at the point of care. RxRevu was referred to as the “Google of Drugs” by CNBC and is currently working with health systems, PBMs, and electronic health records (EHR) vendors. RxRevu’s EHR-embedded technology allows prescribers to view prior authorizations and real-time, patient-specific cost and drug options aligned with formulary and benefit data. This information is provided directly from the payer/PBM to inform the prescriber before medication selection. In addition, the platform provides prescription health analytics to help organizations understand prescribing behavior and drive consistent prescribing practices in line with an organization's best practices.
How much funding has RxRevu raised?
RxRevu has raised $15.0M across 2 rounds on record. The most recent is an undisclosed round of $8.0M announced in Jun 2021.
When did RxRevu last raise funding?
RxRevu's most recent funding round on record is an undisclosed round of $8.0M, announced in Jun 2021.
Who is the CEO of RxRevu?
Carm Huntress is listed as CEO at RxRevu.
Where is RxRevu headquartered?
RxRevu is based in Denver, Colorado, United States.
How many employees does RxRevu have?
RxRevu is in the 51-100 employee band.
How does RxRevu's funding compare to other Data and Analytics startups?
RxRevu's latest round of $8.0M is above the $5.3M median round size for Data and Analytics companies on FundedIQ across 1,842 tracked companies over the last two years.
About FundedIQ's RxRevu Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RxRevu is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.